Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Repligen reported $-2325000 in EBIT for its fiscal quarter ending in September of 2023.

Ebit Change Date
Agilent USD 484M 37M Sep/2023
Align Technology USD 166.35M 5.58M Sep/2023
BioMarin Pharmaceutical USD 25.66M 33.21M Sep/2023
Bristol-Myers Squibb USD 2.72B 194M Sep/2023
Bruker USD 130.9M 34.1M Sep/2023
Catalent USD -26000000 50M Sep/2023
Charles River Laboratories USD 167.7M 1.53M Sep/2023
Danaher USD 1.4B 10M Sep/2023
Dentsply International USD 77M 8M Sep/2023
Exact Sciences USD -76377000 645K Jun/2023
General Electric USD 968M 99M Sep/2023
Illumina USD 154M 177M Sep/2023
IQVIA Holdings USD 549M 5M Sep/2023
Mettler Toledo International USD 278.82M 11.85M Sep/2023
Myriad Genetics USD -25800000 10.4M Sep/2023
Pacific Biosciences Of California USD -73513000 338K Sep/2023
Patterson Companies USD 56.9M 18.68M Sep/2023
Peregrine Pharmaceuticals USD -11222000 9.06M Sep/2023
Pfizer USD -3149000000 5.27B Sep/2023
Repligen USD -2325000 24.26M Sep/2023
Revvity USD 93.69M 14.95M Sep/2023
Thermo Fisher Scientific USD 1.94B 180M Sep/2023
Waters USD 179.43M 20.43M Sep/2023
West Pharmaceutical Services USD 182.1M 4M Sep/2023